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Abstract 
Background: Obstructive sleep apnea (OSA) has been linked to heart disease and 
vice versa. Millions of Americans suffer from this chronic sleep condition, and a great 
number of those affected are unaware they have it. According the American Sleep Apnea 
Association, 80% of patients who fall in the moderate to severe OSA category are 
undiagnosed. Evidence suggest that untreated OSA can lead to atrial fibrillation (AF), 
and other cardiovascular problems. These cardiovascular complications can increase the 
mortality and morbidity of patients who suffer from this sleep syndrome.  
Purpose of Project: The goal of the project was to provide OSA screening to 
patients with implantable cardiac monitors who were observed due to confirmed or 
suspected AF. The aim of this study was to identify the prevalence of those at high risk. 
Our overall purpose was to establish early screening protocols, that could potentially lead 
to early detection and treatment. The screening tool used was the STOP-BANG OSA 
screening tool due to its high sensitivity and specificity for detecting moderate to severe 
cases.  
Methods: Patients were screened for OSA risk by using the STOP-BANG tool. 
The phone screening calls were conducted between the hours of 9:00 am to 5:00pm on 
week days over a period of six months. The scores of 100 patients were obtained, and 
analyzed by using Microsoft Excel software.  
Evaluation/Results: The results showed that 63% of patients screened, scored as 
high risk for OSA. Of those who scored as high risk, 61.90% were males, 38.10% were 
female, 25.39% had previously been diagnosed with OSA, 4.76% were previously 
referred for sleep studies, and 69.84% have never been screened for OSA or referred for a 
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sleep study. These findings suggested that the majority of patients at high risk for OSA 
are neither screened nor referred for sleep studies. The patients found to be at highest risk 
were males, older than 50y/o, obese, with a history of hypertension and syncope.  
Discussion: This project has the potential to provide information regarding the 
prevalence of OSA in patients who are diagnosed or are suspected to have AF. The 
prevalence of OSA in this patient population can give us knowledge regarding their 
health care needs. It can also help providers focus interventions that can potentially 
improve health care outcomes. Early screening can lead to early referral and treatment. 
This in turn may lead to decrease exacerbation of AF, and improved overall quality of life 
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Nurse Practitioner-Led Obstructive Sleep Apnea Screening in Patients with an 
Implantable Cardiac Monitor, and Confirmed or Suspected Atrial Fibrillation.   
Background 
According the American Sleep Apnea Association, 22 million Americans suffer 
from obstructive sleep apnea (OSA), and 80% of those who fall in the moderate to severe 
category are undiagnosed. Untreated OSA can lead to several complications, especially 
of cardiovascular nature. These complications include life threatening conditions such as 
atrial fibrillation (AF), stroke, heart failure, and other cardiovascular issues (American 
Sleep Apnea Association, 2018). There are many studies that explained the consequences 
of OSA, especially those affecting the cardiovascular system. Mannarino, Di Filippo, and 
Pirro (2012), clarified that this syndrome leads to the collapse of the muscle of the 
pharynx during sleep, resulting in airway obstruction. Cardiac arrythmias are among the 
conditions associated with OSA. Butt, Dwivedi, Khair, and Lip (2010), advocated for 
OSA screenings in patients who have cardiovascular disease. They stated that due to the 
cardiovascular risk factors associated with OSA, patients who suffer from cardiac disease 
should be screened for sleep apnea, and patients who are diagnosed with OSA need 
cardiovascular disease screening (Butt et al., 2010). According to the authors, among 
diseases induced or associated with OSA that also increase the mortality and morbidity in 
these patients are: coronary artery disease (CAD), heart failure, cardiac arrhythmias, and 
stroke (Butt et al., 2010).  
Several studies have assessed what the prevalence of OSA in the general 
populations is, as well as in patients who have cardiovascular disease. According to Linz 
et al. (2018), the prevalence of OSA in the general population ranges from 3%-49%, 
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compared to 21-74% in patients with AF. The authors explained that this high 
prevalence, combined with a lack of day-time sleepiness reporting, may warrant the 
consideration of sleep-study evaluation for patients who are considering rhythm control 
therapies (Linz et al., 2018). According to Khan et al. (2019), AF is the most common 
cardiac arrhythmia, and OSA is a risk factor for its onset and reappearance. The authors 
explained that every year is the United States (US) there are 750,000 hospitalizations, and 
130,000 deaths associated with OSA (Khan et al., 2019). Furthermore, Khan et al. (2019), 
stated that OSA prevalence increases to 50% in patients with poorly controlled AF. The 
authors reported that despite the evidence demonstrating an association between OSA 
and AF, the under diagnosis of OSA in patients with cardiovascular issues such as AF, 
continues to be an issue (Khan et al., 2019).   
Nalliah, Sanders, and Kalman (2016), explained that epidemiologic studies 
verified an independent association between AF and OSA, and argued that the 
pathophysiologic process of OSA facilitates the progression of AF. The authors pointed 
at differences in prevalence according to the patient’s sex, and suggested that OSA seems 
to affect males at a higher rate than females. Nalliah, Sanders, and Kalman (2016), 
continued by saying that the prevalence rates of AF and OSA are increasing globally, 
with a prevalence in men and women of 17-31%, and 6.9-9% respectively. Abumuamar, 
Dorian, Newman, and Shapiro (2018), conducted a cohort study and assessed patients 
who were referred to a cardiac clinic. They found a prevalence of OSA in 85% of these 
patients, with the highest prevalence found in males (91% in males compared to 70% in 
women) (Abumuamar et al., 2018).  
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This evidence-based project (EBP) was conducted at a cardiac clinic where 
patients with AF or suspected to have this arrhythmia, are not routinely screened for 
OSA. The need for screening was decided after a review of patient’s charts reflected a 
lack of screening, despite the presence of multiple risk factors associated with OSA. 
Identified risk factors included a diagnosis of AF and other cardiac arrhythmias, diabetes, 
hypertension (HTN), high body mass indexes (BMIs), and obesity.  
Evidence of Problem 
The main strategy of the project was to provide OSA screening to patients 
diagnosed with, or are suspected to have AF. The aim was to detect the prevalence of 
patients at high risk for OSA in this patient population. This decision was made based on 
evidence suggesting that patients with AF and other cardiovascular diseases should be 
screened for OSA (Butt et al., 2010). This sleep disorder is not only a cardiovascular risk 
factor, but it has also been associated with an increase in mortality and morbidity in those 
affected (Butt et al., 2010). The first steps towards pursuing this project included a 
literature review. The majority of articles were found using the database CNAHL. Other 
search engines utilized involved PubMed and Google Scholar. The original search 
yielded 40 articles including one meta-analysis, randomized controlled trials (RCTs), 
several control and cohort studies, as well as interventional crossover studies. There was 
limited data from RCTs found in the literature. The keywords used in the search 
included: OSA prevalence, OSA screening, STOP-BANG questionnaire, atrial fibrillation 
and sleep apnea, sleep apnea and cardiovascular disease, sleep apnea and arrhythmias, 
and sleep apnea screening tools. A total of 31 articles were chosen from the original 
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search for the proposal. These articles were ranked based on the John Hopkins’ evidence-
based level and quality guide (John Hopkins Medicine, 2017).  
A systematic review and a meta-analysis conducted by Nagappa et al. (2015), 
reported that the STOP-BANG questionnaire is a validated tool for the screening of OSA. 
The authors reviewed 9,206 studies, in order to determine this screening tool’s 
effectiveness and accuracy in OSA screening. They concluded that this tool has a high 
performance, especially in the sleep clinics and surgical patient populations. They 
determined that the higher a patient’s scores, the higher the probability of him or her 
having moderate to severe OSA (Nagappa et al., 2015).  
According to Luo, Huang, Zhong, Xiao, and Zhou (2014), the STOP-BANG 
screening tool is superior at predicting OSA than other commonly used tools. The authors 
prospectively included a cohort of 212 from a sleep- disorder clinic. They asked the 
subjects to fill out the STOP-BANG, Epworth, STOP, and Berlin questionnaires, before 
performing and overnight sleep study (polysomnography). They found that the predictive 
value of the STOP-BANG tool was superior in comparison to the other tools. 
Furthermore, they suggested that the STOP-BANG questionnaire should be used more in 
the general population (Luo et al., 2014).  
A randomly selected cohort study conducted by Khan et al. (2019), led OSA 
screenings in patients with persistent AF. They wanted to assess screening rates, and the 
willingness of those at high risk for OSA to have further evaluation. They assessed 254 
patients with persistent AF, and conducted OSA screenings on those who had not been 
previously screened. The screening tool used was the STOP-BANG questionnaire. 
According to Khan et al. (2019), 66% of patients who had AF, had never been screened 
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for OSA. After their screening process was done, they found that 75% of patients scored 
as high risk (Khan et al., 2019). This study emphasized the importance of identifying 
OSA in patients who have AF, since according to the authors, sleep apnea is a risk factor 
in the onset and progression of this cardiac arrhythmia (Khan et al., 2019). They 
concluded by explaining that despite the high association between AF and OSA, the 
majority of patients with persistent AF are not screened for OSA.  Khan et al. (2019) 
emphasized that this lack of screening happens despite these patients having AF and 
other cardiovascular risk factors. These risks factors included obesity, diabetes, and 
hypertension. The authors ended by advocating OSA screening for all patients who have 
AF. However, they highlighted that sleep studies should be reserved for those who are at 
high risk (Khan et al., 2019).  
According to Anter et al. (2017), patients who have OSA, have up to four times 
the risk of developing AF, compared to patients without OSA. They explained that the 
prevalence of OSA in patients with AF is between 10-60%. There is a pathophysiologic 
explanation for the changes that occur in the heart that associate OSA with AF. Anter et 
al. (2017), described that OSA promotes the development of AF by different 
mechanisms. These mechanisms include the shortening of atrial refractoriness, reduction 
of cardiac conduction, and stretching of the atria which may trigger AF (Anter et al. 
(2017). Their study concluded by stating that the high prevalence of OSA in patients with 
AF calls for universal sleep studies, since elimination of triggers can improve arrhythmia-
free survival (Anter et al., 2017).  
Abumuamar, Dorian, Newman, and Shapiro (2018), hypothesized that OSA is 
underdiagnose in patients with AF. They included 123 non-selected patients diagnosed 
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with AF from arrhythmia clinics in Canada, and conducted a two-day sleep study that 
included electroencephalogram recordings. Patients with an Apnea-Hypopnea Index 
(AHI) greater or equal to five, were identified as having OSA. Their final analysis 
included 100 subjects and found that 85% of these patients had OSA, with age and male 
sex as predictors of this syndrome in this patient population. The study concluded that 
OSA is commonly undiagnosed in AF patients, especially women and non-obese patients 
(Abumuamar, Dorian, Newman, & Shapiro, 2018).  
An interventional crossover study conducted by Schlatzer et al. (2015), specified 
that there is evidence suggesting a link between OSA, paroxysmal AF (PAF), and sudden 
cardiac death. In this study, the authors evaluated if changes in intrathoracic pressure 
induced by OSA, cause certain arrhythmias such as premature atrial beats (APBs). They 
also evaluated if this change in intrathoracic pressure, resulted in changed ventricular 
repolarization in patients with PAF (Schlatzer et al., 2015). They conducted 12-lead EKG 
monitoring for 44 patients with OSA, obstructive hypopnea, end-expiratory central 
apnea, and during normal breathing. They also assessed the prevalence of OSA by 
performing sleep studies on these patients. Their study found that APBs occurred in 55% 
of patients with induced obstructive apnea, in 32% of patients with obstructive hypopnea, 
in 14% of those with end-expiratory central apnea, and only in 9% of patients during 
normal breathing (Schlatzer et al., 2015). The authors concluded that simulated OSA 
induces APBs, and leads to significant prolongation of ventricular repolarization. These 
results were significant, since the authors also stated that the majority of PAF are 
triggered by APBs (Schlatzer et al., 2015).  
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Yaranov et al. (2015), stated that OSA is an independent risk factor for ischemic 
stroke, and it is not included in the risk assessment of patients with AF. They conducted a 
study with the aim of assessing the effects OSA has on stroke rates in patients with AF. 
They performed a retrospective chart review, identified patients with AF and new 
diagnosis of OSA, and excluded those with previous stroke history. According to the 
authors, from a total of 5,138 patients who underwent sleep studies, 402 (7.7%) patients 
with previous AF, and who also met inclusion criteria were included in the study 
(Yaranov et al., 2015). They also included 332 (6.4%) patients after the exclusion criteria 
was applied. Their study identified 283 patients with OSA, with men having a higher 
prevalence (73. 1%) (Yaranov et al., 2015). They also found that ischemic strokes were 
more common in patients with OSA (25.4%) when compared to those who did not have it 
(8.2%). Yaranov et al. (2015), concluded that OSA is an independent predictor for stroke.   
The relationship between AF and OSA is explained in many studies and it is 
supported by the evidence. Goyal and Sharma (2013), stated that this association could be 
due in part to a higher prevalence of other risk factors such as, obesity and hypertension 
among OSA patients. However, the authors explained that the association between AF 
and OSA is stronger than the association of AF with other risk factors (Goyal & Sharma 
(2013). The authors also said that OSA is more prevalent in younger patients who have 
AF, and explained that OSA is an independent risk factor for AF (Goyal & Sharma 
(2013). Furthermore, Goyal and Sharma (2013), elucidated that treatments of AF are 
affected as a result of concurrent OSA. They clarified that patient who have AF and 
concurrent OSA, do not respond as well to pharmacologic and no-pharmacologic 
treatments of AF, including cardioversion and ablation therapies (Goyal & Sharma 2013). 
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They also said that the poor response to pharmacologic treatments of AF correlate with 
the severity of OSA, and that there is a high recurrence of AF after ablation in patients 
with OSA (Goyal & Sharma, 2013). This observation is backed by other studies that have 
look at the relationship between these two conditions.   
A meta-analysis conducted by Ng et al. (2011), demonstrated that the presence of 
concurrent OSA with AF poses a 25% increased risk of AF recurrence after ablation 
therapy. Many studies point out the effects OSA has on cardiovascular health. Somers et 
al. (2008), stated that it is estimated that OSA affects millions of Americans, and a large 
proportion of those affected have hypertension or cardiovascular disease. The authors 
explained that data from observational studies of patients with untreated OSA who 
underwent cardioversion due to AF, showed an 82% risk of recurrence of AF within one 
year of the procedure (Somers et al., 2008). According to Goyal and Sharma (2013), 
several studies have demonstrated a high prevalence of OSA in patients who suffer from 
AF, as well as poorer treatment responses of AF when OSA is also present. For these 
reasons, the authors said that patients who have AF should be screened for OSA, and 
those who score as high risk should be considered for a sleep study (Goyal & Sharma, 
2013). 
According to Nalliah et al. (2016), the pathophysiologic processes that occur in 
OSA, work as facilitators for the progression of AF. The authors explained that these 
pathophysiologic changes include autonomic remodeling, inflammation, atrial stretch, 
and impairment of gas exchange. In accordance to their article, treating OSA with 
continuous positive airway pressure (CPAP) can lessen the mechanical problems seen in 
the AF substrate in OSA (Nalliah et al., 2016). The literature supports the consensus that 
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treatment of OSA with CPAP can impact treatment of AF, and reduce complications. 
Goyal and Sharma (2013), explicated that the evidence states that CPAP is an effective 
treatment for OSA, and that treatment with CPAP can improve AF control in patients 
with OSA. 
Bayır et al. (2013), described the association between OSA and AF by explaining 
that the prolongation of interatrial conduction time is related to AF. They stated that 
therapy with CPAP is an effective treatment for OSA, which can translate into a 
decreased risk of AF associated with untreated OSA (Bayır et al., 2013). The authors 
conducted a study with 24 patients diagnosed with OSA, and 18 controls. They measured 
the subjects’ basal interatrial and intraatrial electromechanical delays by doppler 
ultrasound. They then calculated patients’ p wave dispersion (Pd) by 12‐lead EKG, 
before starting CPAP therapy. Six months after the initiation of CPAP therapy, they 
repeated these measurements in patients with OSA. According to Bayır et al. (2013), their 
study found that the interatrial, right and left intraatrial electromechanically delays, and 
Pd were greater in OSA patients prior to CPAP therapy, when compared to control 
groups. The authors noted, that after six months of CPAP therapy, all those values 
significantly improved compared to their baseline at the start of therapy (Bayır et al., 
2013). They concluded by suggesting that the treatment of OSA with CPAP may 
decrease the risk of AF (Bayır et al., 2013). 
According to Kanagala, Narayana, and Friedman (2003), patients with untreated 
OSA have a higher recurrence of AF after cardioversion. Their study demonstrated that 
treatment with CPAP is associated with lower AF recurrence (Kanagala et al., 2003). 
Their prospective study compared the AF recurrences in 27 patients with untreated OSA, 
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and 12 patients with OSA who were using CPAP appropriately. Based on their reports, 
the AF recurrence rates for the patients with untreated OSA, were almost two times 
higher, than for the group who was using CPAP (Kanagala et al., 2003). The authors 
explained that the recurrence rate in the untreated group was 82%, compared to 42% in 
the treated group, and 53% in the control group without OSA (Kanagala et al., 2003). 
Furthermore, the authors described that the recurrence of OSA was higher in the 
untreated group, despite these group of patients having lower BMIs, better functional 
capacity, and less history of hypertension when compared with the treated group 
(Kanagala et al., 2003). According to Kanagala et al. (2003), appropriate treatment with 
CPAP was associated with a reduction in the recurrence of arrhythmias. They stated that 
these findings were independent of age, BMI, HTN, arrhythmia therapies, diabetes, and 
electrocardiogram results. Their study concluded by clarifying that the major determinant 
of AF recurrence, was whether or not these patients were appropriately treated for OSA 
with CPAP (Kanagala et al., 2003).  
Fein et al. (2013), conducted a study with 426 patient who underwent pulmonary 
vein isolation (PVI). From these cohort, 62 patients had a confirmed diagnosis of OSA 
from polysomnography. Out of these 62 patients, 32 were CPAP user, and 30 were not. 
The authors then compared atrial arrhythmias recurrence, need for a repeat ablation 
treatment, and use of antiarrhythmics drugs for a period of 12 months. Fein et al. (2013), 
also compared the outcomes of patients from this same cohort who had OSA, with those 
who did not. According to the authors, CPAP therapy resulted in an AF-free survival rate 
of 71.9% compared to 36.7% in those who were not CPAP users (Fein et al., 2013). They 
also reported that the AF-free survival rate of antiarrhythmic drugs or repeat ablation, 
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were 65.6% vs 33.3% respectively (Fein et al., 2013). Furthermore, the authors clarified 
that the AF recurrence rates in patients who were CPAP users were similar to patients 
who did not have OSA. Fein et al. (2013), specified that the AF recurrence rate following 
PVI was similar in the non-CPAP users’ group and the OSA patients who were managed 
without ablation. However, the recurrence rate was significantly higher in these two 
groups compared to those who were CPAP users (Fein et al., 2013). Their study 
concluded that the treatment of OSA with CPAP in patients undergoing PVI, improved 
arrythmia free survival (Fein et al., 2013). They also clarified that for patients with OSA 
who are not treated with CPAP, PVI is of limited value (Fein et al., 2013).  
The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation 
(ORBIT-AF), is an outpatient registry for patients who suffer from AF in the US. 
Holmqvist et al. (2015), conducted a study aimed at assessing whether patients with OSA 
were more likely to require hospitalizations, had worse outcomes, and progressed to 
persistent AF. A total of 10,132 patients from 176 different sites were included in their 
study. They chose 1,841 (18%) patients with OSA for an analysis on CPAP treatment vs 
no CPAP treatment. After capturing their OSA prevalence rates and CPAP treatment at 
baseline, the participants were followed for 2 years (Holmqvist et al., 2015). The authors 
reported that patients with OSA were more likely to be on rhythm control therapy, and 
had more symptoms than those who did not have OSA (22% vs 16%) (Holmqvist et al., 
2015). According to the results of their study, these subjects were also at higher risk of 
hospitalizations; however, risk of death was similar in both groups. Holmqvist et al. 
(2015), concluded that patients who were on CPAP therapy, were found to be less likely 
to progress to persistent AF, than those who were not on CPAP treatment.  
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This project has the potential to improve outcomes in patients who have AF and 
undiagnosed OSA, by providing early screening. Early screening can lead to early 
detection and referral for sleep studies. The first aim of this project was to conduct a 
nurse practitioner (NP)-lead phone follow-up for OSA screening in patients with 
implantable cardiac monitors and confirmed or suspected AF. The second aim was to 
establish a protocol to facilitate OSA screening for these patients, during their first 
encounter with a provider. The third aim was to suggest a sleep study referral for all 
patients who scored as high risk for OSA, after screening with the STOP-BANG tool. 
OSA screening has the potential to improve early identification, referral, and treatment. 
This is turn can lead to prevention of complications, related to concomitant prevalence of 
OSA and cardiac rhythm disturbances in this patient population.  
Evidence-Base Intervention and Benchmark 
There is overwhelming evidence suggesting an association between AF and OSA, 
yet many patients with cardiovascular disease are not routinely screened for this sleep 
disorder (Khan et al., 2019). According to Khan et al. (2019), a large number of patients 
with AF have undiagnosed sleep apnea. In their study, 66% of participants who had 
persistent AF had never been screened for OSA. After screening was done, they also 
found that 75% were at high risk (Khan et al., 2019).  
The process indicator monitored in this EBP project, was the percentage of 
patients with AF or suspected to have this arrhythmia, who were also at high risk for 
OSA. The decision to screen these patients, was made based on evidence found in the 
literature suggesting that patients who has AF should be screened for OSA, and those 
who are found to be at high risk should be referred for a sleep study (Goyal & Sharma, 
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2013; Khan et al., 2019). Some studies reported that OSA is more prevalent in patients 
who have AF than in the general population, which calls for universal sleep studies in 
these patients (Anter et al., 2017).  
Gami et al. (2004), made a comparison between 151 patients with AF and 312 
patients without history of AF, in order to assess prevalence of OSA. According to the 
authors, there was a higher prevalence of OSA in the group of patients with AF (49% vs 
32%, p=0.0004) (Gami et al., 2004). Their study found that these findings were true, even 
after other risk factors were adjusted such as HTN, age, BMI, and CHF. Based on the 
authors’ reports, patients with AF had double the odds ratio for OSA (Gami et al., 2004). 
Due to the link between OSA and AF, some studies suggested that patients with AF and 
other cardiovascular diseases should be screened for OSA and vice versa (Butt et al., 
2010). According to Mehra et al., (2006), The Sleep Heart Study conducted an analysis 
comparing 228 patients with sleep-breathing disorders (SBD) to 338 patients without 
SBD. Their goal was to assess whether AF, and clinically significant arrhythmias were 
prevalent in patients with SBD (Mehra et al., 2006). Based on their analysis, subjects 
with SDB were more likely to have AF, non-sustained ventricular tachycardia, and 
complex ventricular ectopy when compared to those without SDB (Mehra et al., 2006). 
They also said that the risk of AF increased with the severity of OSA. According to the 
authors, when compared to patients without SDB, patients with SDB had four times the 
odds of AF, almost twice the odds of complex ventricular ectopy, and three times the 
odds of non-sustained ventricular tachycardia (Mehra et al., 2006).  
In this EBP, the goal was to screen as many patients as possible. Sleep apnea 
screenings were conducted weekly for approximately six months. Patients were called, 
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and screened for OSA by using the STOP-BANG screening tool. The STOP-BANG 
screening stool was chosen because it is reliable, and based on clinical characteristics of 
sleep apnea (Stopbang, n.d). According to Chung et al. (2016), it has a sensitivity of 93% 
for detecting moderate to severe OSA, 100% sensitivity for detecting severe cases, a 
negative predictive value (NPV) of 90% in moderate to severe cases, and a NPV of 100% 
in severe OSA. The STOP-BANG screening tool stands for: snoring, tired, observed, 
pressure, body mass index >35kg/m2, age >50 years old, neck circumference 
16inch/41cm or larger and female or 17 inch/43cm or larger and male, gender male 
(Stopbang, n.d). It contains eight yes or no questions, and provides scores from 0-8. A 
score of 0-2 is considered low risk, while a score or 3-4 is measured as moderate risk. 
Patients who score 5-8 are considered high risk. Other criteria for high risk include: 
patients who answer yes to two of the four STOP questions (snoring, tired, observed, and 
pressure) and are male, have a BMI>=35 kg/m2, or have a neck circumference of 
17inches/43cm in males, or 16inches/41cm in females (Stopbang, n.d).  
The aim of this EBP was to screen these patients for OSA, and assess the 
prevalence of those at high risk in this patient population. After prevalence was 
determined, the purpose was to suggest that those who scored as high risk be referred for 
a sleep study, as recommended by the evidence (Goyal & Sharma, 2013; Khan et al., 
2019). Another process indicator included the percentage of patients who are found to be 
at high risk for OSA, and are also sent for sleep studies by their primary care providers 
(PCPs). The last process indicator was the percentage of patients sent for sleep studies, 
who were also diagnosed with OSA. Monitoring these last two process indicators it is 
planned as the second part of this EBP, projected to start on September, 2020. Part two of 
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this EBP is anticipated to be conducted by a second year Doctor of Nursing Practice 
(DNP) student at the University of San Diego (USD). Part two of the project would 
require follow up with patients’ PCPs, as well as patients over the phone. The data would 
be collected weekly, and projected to be completed in six months to one year.  
The outcome indicators included early detection, diagnosis, and treatment of 
OSA. This was planned to be accomplished by implementing OSA screenings as part of 
the clinic’s protocol, after the results of the project were obtained. This protocol would 
entail that the STOP-BANG questionnaire be conducted during the first encounter 
between patients and providers. Establishing screening protocols is a way of providing 
standardization of care, so that patients with high risk factors are routinely screened for 
OSA. The long-term goal of this project is to have 100% rates of sleep study referrals for 
all patients who score as high risk for OSA, within one month of screening. Another 
long-term goal is to offer counseling and education in the reduction of OSA 
complications. Counseling and education ideally should be provided to 100% of patients 
who are refer for sleep studies, within the first month after referral. Education is a great 
way to include patients in their plan of care, and empower them to take an active role in 
their own health. The overall outcome this project hopes to accomplish in the future, is a 
decrease in morbidity and mortality related to the concurrent diagnosis of OSA and AF. 
Evidence Based Practice Question (PICO Question) 
P: In patients with Atrial fibrillation 
I: Does OSA screening by using the STOPBANG tool 
C: Compared to not screening 
O: Leads to early detection, referral, treatment, and better health outcomes? 
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Project Plan and Process 
The goal of the project was to provide OSA screening to patients with implantable 
cardiac monitors who are being monitored due to confirmed or suspected AF. The aims 
of this study were to identify the prevalence of OSA in these patients by using the STOP-
BANG screening tool, establish a protocol for early identification of patients at high risk, 
and suggest sleep study referral for patients who score as high risk. The overall goal was 
for these patients to be identified and diagnosed early, with the hopes of improving AF 
outcomes. 
Facilitators/Stakeholders 
The facilitators and stake holders of this project were the Doctor of Osteopathy 
(DO) and Cardiologist, Dr. Mehran Moussavian, and the Doctor of Philosophy (PhD) and 
Family Nurse Practitioner (FNP), Dr. Liza Alvarez. Both providers were involved in 
monitoring the cardiovascular health and treatment plans of these patients. Another 
facilitator of this EBP was Dr. Joseph Burkard, who is also the faculty advisor and chair 
of the project.  
Project approval Timeline 
The cardiac clinic where the project was implemented is affiliated with Scripps 
Health; however, it did not require their own Institutional Review Board (IRB). USD 
required IRB approval for the project. The letter of approval from the clinic signed by Dr. 
Moussavian, and Dr. Alvarez, was obtained on September 19th, 2018. All required 
documents were submitted to USD’s IRB on September 23rd, 2018, with the assistance of 
Dr. Burkard. USD’s IRB approval was obtained on September 24th, 2018, and modified 
on September 27th, 2018.  
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Measures 
 The STOP-BANG screening tool was used to assess the prevalence of patients at 
high risk for OSA in patients with an implantable cardiac monitor, and confirmed of 
suspected AF. This screening tool was chosen due to its high reliability and sensitivity at 
detection of moderated to severe risk for OSA.  
Project characteristics/Setting 
This EBP was conducted at a cardiology clinic, and included patients who had an 
implantable cardiac monitor who were diagnosed or suspected to have AF. The majority 
of patients were of Hispanic heritage, and spoke English or Spanish. Exclusion criteria 
included patients who did not speak English or Spanish.  
Project Design 
The data was collected over a period of six months. These patients were 
monitored by a Cardiologist or a FNP due to confirmed or suspected AF, or other cardiac 
arrythmias. The reasons for cardiac monitoring included palpitations, syncope, 
cryptogenic shock, suspected AF, and AF management. This DNP project is a follow-up 
of the research project “Early Identification and Intervention in Patients with Atrial 
Fibrillation Using an Implantable Cardiac Monitor to Significantly Improve Guideline-
Based Anticoagulation Therapy in an Outpatient Cardiology Clinic”, conducted at the 
same clinic and authored by Dr. Lisa Alvarez at Hahn School of Nursing at USD.  
The initial patient sample was 271 patients, who’s data was deidentified to protect 
privacy and confidentiality. These patients were monitored for existing or suspected AF 
with implantable cardiac monitors at the clinic prior to data collection. These implantable 
cardiac monitors are placed in patients who have cardiac syndromes such as, arrhythmias. 
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The monitors were also placed in patients who had transient symptoms including 
palpitations, chest pain, dizziness, or for AF management. Most of the data was collected 
retrospectively and included patients’ demographics, and reason for cardiac monitoring. 
The answers to several of the STOP-BANG questions were also collected retrospectively 
including BMI, history of HTN, sex, and age. The rest of the questions were obtained via 
telephone calls. These phone calls were conducted on a weekly basis, for the first six 
months after IRB approval was obtained (October, 2018- March, 2019).  
Data Collection Plan and Analysis 
 The phone calls were conducted between the hours of 9:00 am and 5:00 pm every 
Wednesday, for six months after IRB approval was obtained. Patients were asked to 
answers the questions on the STOP-BANG screening tool. Due to the time, and day of 
the week the phone calls where conducted, it was anticipated that several patients may 
not answer the phones during the first efforts. For this reason, the phone calls were 
attempted three times over the course of those six months. The aim was to screen as 
many patients as possible, with a minimum goal of screening at least 100 patients. Their 
STOP-BANG responses, and scores were aggregated in an excel spread sheet manually. 
The percentage of patients who scored as high risk for OSA was then calculated, based 
on the STOP-BANG tool’s criteria. The scores of 100 patients was able to be recorded at 
the end of the data collection period. The data was analyzed by Microsoft Excel in Oct, 
2019, but most of the calculations were done manually. Results were presented to all 
stakeholder, and facilitators by a power point presentation at the clinic were the project 
was conducted. This stakeholder presentation took place on January 20th, 2020. A poster 
power point presentation was conducted at USD on March, 12th, 2020. The abstract and 
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power point poster presentation for this project were sent to the California Association 
for Nurse Practitioners (CANP) 43rd annual conference, and was accepted on Sept 16th, 
2019.  
Barriers/Limitations 
One of the limitations of this project included the inability of patients to answer 
all the questions in the STOP-BANG questionnaire. Only 12% patients knew their neck 
circumference measures. Another question inquired whether someone had witnessed the 
patients stop breathing during sleep; the majority could not answer this question. This 
project may not be able to be generalized to the general population, since the data was 
collected on a small sample of the population who also had similar demographic 
characteristics. Another limitation of the project was that all data, scores and percentages 
calculations were done manually; therefore, subjected to human error.  
Other anticipated barriers concerned the implementation of the project. These 
included resistances to establish OSA screening protocols by the clinic where the project 
was conducted. Besides the initial OSA screenings conducted as part of this EBP (part 
one), a screening protocol was not implemented as part of the clinic’s guidelines by end 
of the project. Despite the results, and a suggestion for sleep studies to patients at high 
risk during the stakeholder presentation, PCPs were not suggested to order sleep studies 
for these patients at the end of part one of this EBP. Another anticipated barrier, included 
resistance from patient’s PCPs to order the suggested sleep studies for those identified as 
high risk for OSA. Further studies need to be conducted in order to assess the percentage 
of patients referred for sleep studies, those with definitive OSA diagnosis, outcomes of 
treatment and patient education, and overall patients’ outcomes.  
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EBP Model 
The model chosen as a guide for the implementation of this project was the Iowa 
Model of evidence-based practice. The Iowa model is composed of several steps 
including the selection of a topic, team formation, evidence retrieval and grading, EBP 
standard development, implementation, and evaluation (Doody & Doody, 2011). The 
main reason this model was chosen for this EBP, was its emphasis on the use of research 
evidence to guide practice change. Another reason for its use, was its encouragement for 
the inclusion of the health care team (including patients) in decision making (Dontje, 
2007).  
The topic identified as the basis for this project was the prevalence of OSA in 
patients who have AF. This problem was of upmost priority since there is evidence 
suggesting an association between OSA and AF, as well as OSA and AF exacerbation. 
The team included a DNP student at USD, Yarlenis Miranda; a FNP, Dr. Lisa Alvarez; a 
Cardiologist, Dr. Mehran Moussavian; and the project’s chair and faculty advisor, Dr. 
Burkard. In the development of the plan, the literature was reviewed before and during 
the project’s development and implementation. Once the OSA screening was 
implemented, the data was analyzed, and the prevalence of patients at high risk for OSA 
in this cohort was obtained. Part two of the project is projected to begin in September, 
2020. This second part of the EBP is intended to assess percentages of sleep study 
referrals, prevalence of OSA diagnosis, and treatment follow up.  
Evaluation of Results  
From the data analysis, the scores of 100 patients out of the initial 271 subjects 
were obtained. These 100 scores were attained after screening phone calls were attempted 
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three times over the course of six months. The results showed that 63 % of patients were 
at high risk of having OSA. These results correlated with evidence suggesting that the 
majority of patients with AF and other cardiovascular risk factors, are not routinely 
screened for OSA (Khan et al., 2019). From the 63% who score as high risk, 61.90% 
were men and 38.10% were women. These findings also correlated with evidence 
suggesting a higher OSA risk in men (Abumuamar et al., 2018). From the percentage 
found to be at high risk, 25.39% had previously been diagnosed, 4.76% were previously 
referred for sleep studies, and 69.84% have never been screened or referred for a sleep 
study. These findings also correlate with evidence suggesting that the majority of patients 
at high risk for OSA are “falling through the cracks”, and are neither screened for OSA, 
nor referred for sleep studies (Khan et al., 2019). Untreated OSA can negatively affect 
these patient’s outcomes. This EBP project also found that hypertension, older age, 
obesity, and male sex play a role in the increased risks for sleep apnea. Among the 
screened subjects found to be at high risk for this sleep disorder, 90.48% had a history of 
HTN, 88.8% were older than 50 years old (median and average age of 62 years old), 
55.5% were obese, 30.16% were overweight (average and median BMI were 32.60% and 
31.64 respectively), and 61.9% were male. Another observation of the project was that 
among those who scored as high risk, the most common reason for cardiac monitoring 
was syncope (33.33%), followed by palpitations (19.05%), suspected AF (19.05%), 
cryptogenic shock (14.29%), unknown cause (7.93%), and at last the management of 
existing AF (6.35%). After the data was analyzed, we concluded that the patients at 
highest risk were males, older than 50 years old, obese, with a history of hypertension 
and syncope.  
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The data was displayed as a percentage in graphs and pie charts, since it paints a 
better picture of the need to screen these patients. The use of percentages makes the 
results easier to understand, especially for people who are not familiar with other 
statistical measures or have low literacy levels. Percentages also simplifies the 
comparison of different values, and quantify the need to establish a screening protocol in 
this practice. The results were showcased as pie charts and bar graphs. The pie charts 
simplified the results by showing the relationship between the different criteria, and 
portraying the percentages as part of a whole picture. The graphs help compared the 
results of the project while simplifying their understanding. Figures 1-5 makes is easier 
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Figure 2. Risk Levels of OSA 
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Figure 4: Percentages of Diagnosed, Referred, and Screened 
 
Figure 5: Patients Demographics and Risk Factors 
The purpose of this project was to provide early screening of OSA to patients 
diagnosed with or suspected to have AF, and detect the prevalence of patients at high 
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those at high risk to be referred for a sleep study. Early screening and referral can lead to 
early diagnosis and treatment. Evidence should guide practice, especially when it can 
make a difference in patients’ outcomes. Based on the evidence, early intervention with 
OSA screening and treatment, can decrease complications associated with this cardiac 
arrythmia. This in turn can decrease morbidity and mortality in this patient population. 
This intervention also has the potential of reducing the cost associated with complications 
of AF for patients, and health care institutions. Cost reduction can provide relief 
pertaining to burden of disease. It can also improve access to quality health care for those 
affected.  
Cost/Benefit Analysis  
According to Knauert, Naik, Gillespie, and Kryger (2015), untreated OSA 
increases the risk of several conditions including arrhythmias, coronary artery disease 
(CAD), heart failure, and stroke. The authors said that AF is very common in patients 
who have sleep apnea, and untreated sleep apnea is a predictor for AF recurrence 
(Knauert et al., 2015). They also highlighted that patients who have severe OSA, are less 
likely to respond to therapy with antiarrhythmic drugs. Based on their article, the annual 
cost of treatment for AF for a single patient is $8705, which accounts for $26 billion 
annually in the US (Knauert et al., 2015).  
Knauert et al. (2015), also reported that patients with OSA are at higher risk of 
having CAD, with men being at high risk for negative cardiovascular complications 
(myocardial infarctions) if OSA is not treated. According Knauert et al. (2015), the cost 
to treat myocardial infarction is $14,000 per patient per year. They explained that this 
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complication can be prevented with the consistent use of CPAP therapy (Knauert et al., 
2015).  
Another complication of untreated OSA is the development of ischemic stroke.  
Knauert et al. (2015), reported that this condition can be attenuated with OSA treatment. 
They stated that annual cost of treatment for a single patient with stroke ranges from 
$100,000 - $300,000 (Knauert et al., 2015). Early detection and treatment of OSA can 
decrease complications associated with concurrent cardiac disease. By decreasing 
complications, we can make a great difference in reducing the overall cost associated 
with treatment of these conditions.  
Most of the data for this project was collected retrospectively, therefore, there was 
no cost related to establishing appointments. It required access to a computer, and 
telephone for the initial data collection. All phone calls were conducted by a DNP 
student. This step incurred no additional cost to the clinic or the student, other than the 
time spent calling patients. Training for stakeholders, providers, and staff members would 
require no additional cost, since this training would be provided during business hours at 
monthly staff meetings.  
According to the American Sleep Association (n.d), the cost of at home sleep 
studies varies from $100-$500, which is covered by most insurance companies. The 
American Sleep Association (n.d), also stated that the estimated average price for a 
CPAP machine is $850. Based on Brannon (2019), CPAP machines are also covered by 
insurance companies, so long as the patient has paid the deductible.  
The hypothetical cost and benefits of the project, based on decrease AF 
complications alone were estimated on Table 1. These numbers are theoretical, based on 
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projected costs of materials and information found on two articles (Brannon, 2019; 
Knauert et al., 2015); further literature review may be needed. The numbers were 
manually calculated; therefore, subjected to human error.  
Table 1: Cost-Benefit Analysis  
Resource Cost Rationale 
Administrative 
training 
$0  OSA screening was be conducted 
by DNP student weekly.  
Provider and Staff 
training  
$0 This training can be provided 
during business hours, at monthly 




cents per copy 






This can include flyers and 
brochures that could be distributed 
to patients and staff members, as 
well as a poster board that will be 
placed in the clinic’s break room. 
Sleep Study $300  This cost is typically be covered by 
insurance companies. 
CPAP machine $850 This cost is typically covered by 
insurance companies. 
Total  $1,650 Approximate cost of project 
implementation including cost of 
sleep study and CPAP treatment.  




Atrial Fibrillation  
(100 
patients x $8,750 
per patient per 
year) 
100 patients screened x 
$8,750 cost of AF treatment 
per patient per year = 
$875,000 per year 
 
 
Untreated OSA increases risk of 
AF exacerbations, and 
antiarrhythmic therapy resistance.  
Total            $875,000 per year Approximate annual cost of 




Decrease mortality and morbidity related to OSA complications 
including AF exacerbations.  
Total 
Savings   
$848,350 of possible annual savings related to decrease 
complications of OSA due to early detection, and treatment. 
ROI= 51,315% 
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Anticipated Project Outcomes 
The short-term outcomes include providing OSA screening to 100% of patients 
with confirmed or suspected AF, within six months of the project implementation. The 
second short-term outcome is to suggest a sleep study to 100% of patients who score as 
high risk for OSA, within six months of project implementation. The first long-term 
outcome is to provide sleep apnea counseling to 100% of patients suggested for a sleep 
study, within one year of project implementation. The second-long term outcome is to 
incorporate OSA screening for all patients with AF at their first clinical encounter, within 
the one year of project implementation. Meeting these outcomes can have a great impact 
on the management of patients with diagnosed or suspected to have AF, since it can 
detect risk of OSA, and also the course of treatment.  
Implications for Practice 
This project has the potential to increase OSA screening in patients with AF or 
suspected to have AF. Establishing a protocol to screen these patients during the first 
encounter with a provider can lead to early detection, sleep study referral, and ultimately 
early treatment. By increasing the percentage of patients with AF who are screened for 
sleep apnea, the number of AF exacerbations, complications, morbidity and mortality 
could also be decreased. 
Communication Plan 
The project’s results were disseminated as a power point, and poster 
presentations. The first step was to present the results to all stakeholders including Dr. 
Lisa Alvarez, Dr. Mehran Moussavian, and Dr. Joseph Burkard. The stakeholder 
presentation took place at the clinic on Jan 20th, 2020. Based on the results of the project, 
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a recommendation was given to the stakeholders. This recommendation advised that 
patients’ who scored as high risk for OSA should be referred for a sleep study; therefore, 
their PCPs should be notified and advised to issue a referral. The sustainability of the 
project was discussed with all stakeholders, after the results’ presentation. A discussion 
about the continuation with the second part of the project was conducted with Dr. Lisa 
Alvarez. The second part of the EBP is anticipated to be carried out by a second year 
DNP student, who will be selected by Dr. Joseph Burkard.  
The project’s abstract for poster presentation was submitted to the California 
Association for Nurse Practitioners (CANP) 43rd annual educational conference. The 
acceptance letter from CANP for poster presentation was received on September 16th, 
2019. This conference was to take place in the county of Riverside on March 18-22, 
2020. The manuscript is anticipated to be submitted for publication to the Journal of 
Clinical Nursing (JCN). This journal is an international and scientific journal that 
advocates for the development of knowledge applicable to the nursing practice (Journal 
of Clinical Nursing, n.d). The journal was chosen because it publishes peer-reviewed 
clinical articles, original research, and issues that help nurse practitioners become better 
at their practice. It also advocates for meeting practice needs, and it encourages feedback 
and advocacy. JCN also focuses on the importance of policy and its role in shaping 
practice outcomes.  
Sustainability  
The most important step in order to ensure sustainability, is education of 
providers, stakeholders, and members of the staff at the clinic. There needs to be an 
emphasis in education regarding the association of cardiac disease and OSA. There is 
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also a need to highlight the importance of early detection and treatment, and their role in 
decreasing morbidity and mortality. The second step is to establish a protocol, where 
patients are screened during their first encounter with their provider. This clinic 
specializes in the care of patients who have cardiac disease. Screening for OSA during 
the first encounter will benefit all patients, not just the ones who have AF. In order for the 
project to be successful, all members of the staff also need to be invested in the project’s 
success, as a way to ensure compliance with the screening protocol. Another way to 
ensure sustainability, is to alter the electronic health record (EHR), so that patients 
detected as high risk for OSA are flagged. This step will act as a reminder for providers, 
so that sleep study referrals are ordered as soon as possible.  
The project’s champion at the clinic is Dr. Lisa Alvarez. Dr. Alvarez has an 
interest in monitoring the long-term effects of OSA and AF. As previously mentioned, 
this project will have a second part that projected to start on September, 2020. This long-
term continuation of the EBP will also ensure sustainability. The plan for part two of the 
project, is to conduct follow up phone calls with patients who were suggested for a sleep 
study. Compliance with sleep studies, and the percentage of OSA diagnosis can be 
tracked, and recorded in the data sheet. The plan also entails providing counseling to 
patients, on ways to reduce risk factors associated with OSA. Providing education to 
patients is another way to ensure sustainability of project. The main goal is to have a 
positive impact in the lives of patients, and improve their outcomes.  
Conclusion 
This project provided information regarding the prevalence of OSA in patients 
who are diagnosed with or suspected to have AF at a cardiac clinic. The results of this 
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project showed that 63% of patient that met the inclusion criteria were at high risk for 
OSA. The majority of those at high risk were males. Other risk factors patients at high 
risk had in common included a history of HTN, obesity or overweight, and an age greater 
than 50 years old. The results of this project correlated with evidence that suggested that 
patient with cardiovascular disease, especially AF, are at risk of having undiagnosed 
OSA. There are many studies that explained that undiagnosed OSA is among the reasons 
for AF exacerbations and development of other cardiac arrhythmias. For these reasons, 
these patients should be screened routinely for OSA. Early identification, referral and 
treatment may lead to decrease exacerbation of AF, and improved overall quality of life 
for patients who have coexisting AF and OSA.   
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